Sandra Borkowski

1.6k total citations
16 papers, 1.3k citations indexed

About

Sandra Borkowski is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Sandra Borkowski has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Sandra Borkowski's work include Radiopharmaceutical Chemistry and Applications (11 papers), Peptidase Inhibition and Analysis (5 papers) and Neuropeptides and Animal Physiology (5 papers). Sandra Borkowski is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Peptidase Inhibition and Analysis (5 papers) and Neuropeptides and Animal Physiology (5 papers). Sandra Borkowski collaborates with scholars based in Germany, Switzerland and United States. Sandra Borkowski's co-authors include Keith Graham, Ludger M. Dinkelborg, Dietmar Berndorff, Helmut R. Maëcke, Jean Claude Reubi, Rosalba Mansi, Stephen L. Warren, Ying-Fon Chang, Gary Cook and Ty Gould and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Bioconjugate Chemistry.

In The Last Decade

Sandra Borkowski

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Borkowski Germany	14	783	522	471	317	205	16	1.3k
Tammy L. Rold United States	20	875 1.1×	585 1.1×	263 0.6×	298 0.9×	193 0.9×	34	1.2k
Subhani M. Okarvi Saudi Arabia	17	851 1.1×	521 1.0×	415 0.9×	163 0.5×	189 0.9×	46	1.2k
Gary L. Sieckman United States	24	1.3k 1.6×	837 1.6×	344 0.7×	439 1.4×	341 1.7×	42	1.7k
Jochen Schuhmacher Germany	17	1000 1.3×	513 1.0×	329 0.7×	188 0.6×	413 2.0×	27	1.4k
Sylvie Froidevaux Switzerland	15	794 1.0×	550 1.1×	414 0.9×	110 0.3×	435 2.1×	38	1.4k
Michel Tohme United States	16	998 1.3×	423 0.8×	447 0.9×	189 0.6×	100 0.5×	23	1.5k
Yubin Miao United States	29	1.7k 2.1×	809 1.5×	683 1.5×	263 0.8×	120 0.6×	80	2.1k
Habibe Karacay United States	30	1.8k 2.2×	668 1.3×	550 1.2×	290 0.9×	136 0.7×	42	2.1k
Rosalba Mansi Switzerland	26	1.3k 1.6×	1.2k 2.2×	428 0.9×	471 1.5×	813 4.0×	59	2.1k
Bogdan Mitran Sweden	25	1.1k 1.4×	688 1.3×	370 0.8×	263 0.8×	120 0.6×	55	1.3k

Countries citing papers authored by Sandra Borkowski

Since Specialization

Citations

This map shows the geographic impact of Sandra Borkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Borkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Borkowski more than expected).

Fields of papers citing papers by Sandra Borkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Borkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Borkowski. The network helps show where Sandra Borkowski may publish in the future.

Co-authorship network of co-authors of Sandra Borkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Borkowski. A scholar is included among the top collaborators of Sandra Borkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Borkowski. Sandra Borkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Sah, Bert-Ram, Irene A. Burger, Roger Schibli, et al.. (2015). Dosimetry and First Clinical Evaluation of the New ¹⁸F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer. Journal of Nuclear Medicine. 56(3). 372–378. 58 indexed citations

Dumont, Rebecca A., Maria‐Luisa Tamma, Friederike Braun, et al.. (2013). Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin. Journal of Nuclear Medicine. 54(5). 762–769. 75 indexed citations

Lesche, Ralf, Georg Kettschau, Niels Böhnke, et al.. (2013). Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 41(1). 89–101. 29 indexed citations

Kähkönen, Esa, Ivan Jambor, Jukka Kemppainen, et al.. (2013). In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548. Clinical Cancer Research. 19(19). 5434–5443. 162 indexed citations

Roivainen, Anne, Esa Kähkönen, Pauliina Luoto, et al.. (2013). Plasma Pharmacokinetics, Whole-Body Distribution, Metabolism, and Radiation Dosimetry of ⁶⁸Ga Bombesin Antagonist BAY 86-7548 in Healthy Men. Journal of Nuclear Medicine. 54(6). 867–872. 92 indexed citations

Borkowski, Sandra, Christina Hultsch, Bernd Elger, et al.. (2012). Preclinical validation of the Ga-68-bombesin antagonist BAY 86-7548 for a phase I study in prostate cancer patients. 53. 177–177. 1 indexed citations

Honer, Michael, Linjing Mu, Timo Stellfeld, et al.. (2011). ¹⁸F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors. Journal of Nuclear Medicine. 52(2). 270–278. 55 indexed citations

Schäfer, Niklaus, Ray Valencia, Sandra Borkowski, et al.. (2011). Abstract 4139: Diagnostic performance of the F-18 labeled bombesin analog BAY 86-4367 in patients with primary prostate cancer. Cancer Research. 71(8_Supplement). 4139–4139. 1 indexed citations

Mansi, Rosalba, Xuejuan Wang, Flavio Forrer, et al.. (2010). Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. European Journal of Nuclear Medicine and Molecular Imaging. 38(1). 97–107. 166 indexed citations

10.

Mu, Linjing, Michael Honer, Miljen Martić, et al.. (2010). In Vitro and in Vivo Characterization of Novel ¹⁸F-Labeled Bombesin Analogues for Targeting GRPR-Positive Tumors. Bioconjugate Chemistry. 21(10). 1864–1871. 28 indexed citations

11.

Mu, Linjing, P. August Schubiger, Simon M. Ametamey, et al.. (2009). Direct One-Step¹⁸F-Labeling of Peptides via Nucleophilic Aromatic Substitution. Bioconjugate Chemistry. 20(12). 2254–2261. 79 indexed citations

12.

Höhne, Aileen, Linjing Mu, Michael Honer, et al.. (2008). Synthesis, ¹⁸F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks. Bioconjugate Chemistry. 19(9). 1871–1879. 110 indexed citations

13.

Moosmayer, Dieter, Dietmar Berndorff, Chien‐Hsing Chang, et al.. (2006). Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors. Clinical Cancer Research. 12(18). 5587–5595. 29 indexed citations

14.

Hicke, Brian J., Andrew Stephens, Ty Gould, et al.. (2006). Tumor targeting by an aptamer.. PubMed. 47(4). 668–78. 295 indexed citations

15.

Berndorff, Dietmar, Sandra Borkowski, Dieter Moosmayer, et al.. (2006). Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments.. PubMed. 47(10). 1707–16. 58 indexed citations

16.

Berndorff, Dietmar, Sandra Borkowski, Matthias Friebe, et al.. (2005). Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate. Clinical Cancer Research. 11(19). 7053s–7063s. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact